2 results
Approved WMOPending
To evaluate the value of a TAP-block for the reduction of postoperative bladder spasm after RALP for prostate cancer
Approved WMOWill not start
Primary: efficacy of GSK1605786 at week 12 following twice daily administration at 500 mg in patients with active ulcerative colitis. Secondary: safety and tolerability, time course of the efficacy of GSK1605786 continued for up to 16 weeks, anti-…